Загрузка...
Evaluation of the Tolerability of Switching Patients on Chronic Full μ-Opioid Agonist Therapy to Buccal Buprenorphine
Objective Assess whether patients with chronic pain receiving 80 to 220 mg oral morphine sulfate equivalent of a full μ-opioid agonist could be transitioned to buccal buprenorphine at approximately 50% of their full dose without inducing opioid withdrawal or sacrificing analgesic efficacy. Methods. ...
Сохранить в:
| Опубликовано в: : | Pain Med |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4984426/ https://ncbi.nlm.nih.gov/pubmed/26917621 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/pm/pnv110 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|